0001613103-23-000082.txt : 20230802 0001613103-23-000082.hdr.sgml : 20230802 20230802201356 ACCESSION NUMBER: 0001613103-23-000082 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230802 DATE AS OF CHANGE: 20230802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Wall Brett A. CENTRAL INDEX KEY: 0001473812 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36820 FILM NUMBER: 231137641 MAIL ADDRESS: STREET 1: 710 MEDTRONIC PARKWAY STREET 2: LC300 CITY: MINNEAPOLIS STATE: MN ZIP: 55432 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medtronic plc CENTRAL INDEX KEY: 0001613103 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 000000000 FISCAL YEAR END: 0427 BUSINESS ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 01135314381700 MAIL ADDRESS: STREET 1: 20 ON HATCH, LOWER HATCH STREET CITY: DUBLIN STATE: L2 ZIP: 2 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Ltd DATE OF NAME CHANGE: 20150112 FORMER COMPANY: FORMER CONFORMED NAME: Medtronic Holdings Ltd DATE OF NAME CHANGE: 20140711 FORMER COMPANY: FORMER CONFORMED NAME: Kalani I Ltd DATE OF NAME CHANGE: 20140709 4 1 wk-form4_1691021627.xml FORM 4 X0508 4 2023-07-31 0 0001613103 Medtronic plc MDT 0001473812 Wall Brett A. 710 MEDTRONIC PARKWAY MINNEAPOLIS MN 55432 0 1 0 0 EVP & Pres Neuroscience 0 Ordinary Shares 2023-07-31 4 A 0 9686 0 A 33634 D Performance Share Units 2023-07-31 4 A 0 24214 0 A Performance Share Unit 24214 24214 D Stock Option (Right to Buy) 87.76 2023-07-31 4 M 0 68196 0 A 2033-07-31 Ordinary Shares 68196 68196 D Restrictions on the award shall lapse 100% on the third anniversary of the Grant Date. Each performance share unit represents a contingent right to receive one share of Medtronic common stock. The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 24,214 shares will be issued. If maximum performance metrics are achieved, 48,428 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares. Vests on July 31, 2026. These options become exercisable at the rate of 25% of the shares granted beginning on the first anniversary of the grant. /s/ Thomas L. Osteraas, attorney-in-fact 2023-08-02